Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 3886 AL 3900

[Episodic memory and Alzheimer's disease: evolution of theories and clinical assessment tools]

Launay A, Taconnat L, Vanneste S, Baudouin A.

Geriatr Psychol Neuropsychiatr Vieil. 2023 Dec 1;21(4):469-476. doi: 10.1684/pnv.2023.1139.

Antipsychotics in Alzheimer's Disease: Current Status and Therapeutic Alternatives

Maziero MP, Rocha NP, Teixeira AL.

Curr Alzheimer Res. 2023;20(10):682-691. doi: 10.2174/0115672050287534240215052417.

Cognitive impairment in bipolar disorder in comparison to mild cognitive impairment and dementia: a systematic review

Simjanoski M, McIntyre A, Kapczinski F, Cardoso TA.

Trends Psychiatry Psychother. 2023 Feb 20;44:e20210300. doi: 10.47626/2237-6089-2021-0300.

Assessing Equitable Inclusion of Underrepresented Older Adults in Alzheimer's Disease, Related Cognitive Disorders, and Aging-Related Research: A Scoping Review

Godbole N, Kwon SC, Beasley JM, Roberts T, Kranick J, Smilowitz J, Park A, Sherman SE, Trinh-Shevrin C, Chodosh J.

Gerontologist. 2023 Jul 18;63(6):1067-1077. doi: 10.1093/geront/gnac060.

Bipolar Disorder and Manic-Like Symptoms in Alzheimer's, Vascular and Frontotemporal Dementia: A Systematic Review

Elefante C, Brancati GE, Torrigiani S, Amadori S, Ricciardulli S, Pistolesi G, Lattanzi L, Perugi G.

Curr Neuropharmacol. 2023;21(12):2516-2542. doi: 10.2174/1570159X20666220706110157.

Trail Making Test Error Analysis in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Dementia With and Without Depression

Hafiz NJ, Lohse A, Haas R, Reiche S, Sedlaczek L, Brandl EJ, Riemer TG.

Arch Clin Neuropsychol. 2023 Jan 21;38(1):25-36. doi: 10.1093/arclin/acac065.

A Systematic Review of Subjective Cognitive Characteristics Predictive of Longitudinal Outcomes in Older Adults

Earl Robertson F, Jacova C.

Gerontologist. 2023 May 9;63(4):700-716. doi: 10.1093/geront/gnac109.

A Case of Atypical Alzheimer's Disease With Clinical Manifestation That Straddled the Boundary Between Primary Progressive Aphasia and Posterior Cortical Atrophy

Chandregowda A, Clark HM, Machulda MM, Pham NTT, Lowe VJ, Josephs KA, Whitwell JL.

Neurologist. 2023 May 1;28(3):195-197. doi: 10.1097/NRL.0000000000000458.

Revisiting global cognitive and functional state 13 years after a clinical trial of lithium for mild cognitive impairment

Damiano RF, Loureiro JC, Pais MV, Pereira RF, Corradi MM, Di Santi T, Bezerra GAM, Radanovic M, Talib LL, Forlenza OV.

Braz J Psychiatry. 2023 Mar 11;45(1):46-49. doi: 10.47626/1516-4446-2022-2767.

COVID-19 as a Risk Factor for Alzheimer's Disease

Golzari-Sorkheh M, Weaver DF, Reed MA.

J Alzheimers Dis. 2023;91(1):1-23. doi: 10.3233/JAD-220800.

Real-World Use of Symptomatic Treatments in Early Alzheimer's Disease

Garcia MJ, Leadley R, Lang S, Ross J, Vinand E, Ballard C, Gsteiger S.

J Alzheimers Dis. 2023;91(1):151-167. doi: 10.3233/JAD-220471.

Association Between Oral Bacteria and Alzheimer's Disease: A Systematic Review and Meta-Analysis

Liu S, Dashper SG, Zhao R.

J Alzheimers Dis. 2023;91(1):129-150. doi: 10.3233/JAD-220627.

Role of Flavonoids in Management of Various Biological Targets in Alzheimer's Disease: Evidence from Preclinical to Clinical Studies

Alharbi KS, Javed Shaikh MA, Imam SS, Alshehri S, Ghoneim MM, Almalki WH, Singh SK, Kumar D, Kumar AP, Dua K, Chellappan DK, Paudel KR, Gupta G.

Curr Med Chem. 2023;30(18):2061-2074. doi: 10.2174/0929867330666221122115212.

Impact of Computerized Cognitive Training on Default Mode Network Connectivity in Subjects at Risk for Alzheimer's Disease: A 78-week Randomized Controlled Trial

Petrella JR, Michael AM, Qian M, Nwosu A, Sneed J, Goldberg TE, Devanand DP, Doraiswamy PM.

J Alzheimers Dis. 2023;91(1):483-494. doi: 10.3233/JAD-220946.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias